Diabetes exacerbates inflammatory responses to ischemia-reperfusion

Area of Science:

• Microvascular physiology
• Diabetes mellitus pathophysiology
• Inflammatory responses

Background:

• Diabetes mellitus is linked to increased ischemic organ damage.
• Understanding microvascular dysfunction in diabetes is crucial for preventing organ injury.

Purpose of the Study:

• Compare leukocyte-endothelial cell interactions and albumin leakage in response to ischemia-reperfusion between control, diabetic, and hyperglycemic rats.
• Identify molecular factors driving leukocyte accumulation in diabetic ischemia-reperfusion.

Main Methods:

• Induce diabetes using streptozotocin or hyperglycemia via glucose infusion in rats.
• Examine mesenteric venule responses to ischemia-reperfusion, including leukocyte adhesion, emigration, and albumin leakage.
• Utilize antibodies against specific cell adhesion molecules (CD11/CD18, ICAM-1, P-selectin, L-selectin) to probe molecular mechanisms.

Main Results:

• Diabetic rats exhibited increased spontaneous albumin leakage and exaggerated leukocyte adhesion, emigration, and albumin leakage post-ischemia-reperfusion compared to controls.
• Hyperglycemia alone did not alter microvascular responses to ischemia-reperfusion.
• Antibodies against CD11/CD18, ICAM-1, and P-selectin reduced leukocyte accumulation in diabetic rats, but did not affect albumin leakage.

Conclusions:

• Diabetes mellitus significantly amplifies leukocyte-endothelial cell adhesion and albumin leakage during ischemia-reperfusion.
• Enhanced leukocyte accumulation in diabetic ischemia-reperfusion involves CD11/CD18-ICAM-1 and P-selectin pathways.
• The exaggerated albumin leakage in diabetic ischemia-reperfusion is independent of recruited inflammatory cells.